orphenadrine has been researched along with Myotonia in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Myotonia: Prolonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerstenbrand, F | 1 |
| Mamoli, B | 1 |
| Tilscher, H | 1 |
1 other study available for orphenadrine and Myotonia
| Article | Year |
|---|---|
[Therapeutic experiences with a myotinolytic agent (orphenadrine citrate) in vertebral, radicular disorders].
Topics: Acetaminophen; Cervical Vertebrae; Citrates; Humans; Lumbar Vertebrae; Myotonia; Orphenadrine; Perip | 1973 |